Drug slashes migraine days by half in early trial — and it may work with completely 'new mechanism'

Tuesday, July 1, 2025 - 15:45 in Health & Medicine

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.

Read the whole article on Live Science

More from Live Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net